chr19-49880393-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024682.3(TBC1D17):c.310C>T(p.Pro104Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,586 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024682.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBC1D17 | NM_024682.3 | c.310C>T | p.Pro104Ser | missense_variant | Exon 4 of 17 | ENST00000221543.10 | NP_078958.2 | |
TBC1D17 | NM_001168222.2 | c.211C>T | p.Pro71Ser | missense_variant | Exon 3 of 16 | NP_001161694.1 | ||
TBC1D17 | XM_047439444.1 | c.310C>T | p.Pro104Ser | missense_variant | Exon 4 of 16 | XP_047295400.1 | ||
TBC1D17 | XM_011527317.4 | c.310C>T | p.Pro104Ser | missense_variant | Exon 4 of 14 | XP_011525619.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461352Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 726954 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74374 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.310C>T (p.P104S) alteration is located in exon 4 (coding exon 4) of the TBC1D17 gene. This alteration results from a C to T substitution at nucleotide position 310, causing the proline (P) at amino acid position 104 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at